OYSTER POINT PHARMA INC (OYST) Stock News
NASDAQ:OYST - Nasdaq - US69242L1061 - Common Stock - Currency: USD
OYST Latest News, Press Relases and Analysis
Health Care Becomes Most Overweighted Sector As Hedge Funds Crowd Into Magnificent 7
Goldman Sachs' Hedge Fund Trend Monitor highlights concentration in mega-caps, with optimism in AI and health care.
The 7 Best Crypto and Stocks to Buy as Christmas Gifts This Year
These stocks to buy as Christmas gifts provide a number of reasons for investors to rejoice this holiday season.
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates IMGO, ELVT, LBC, OYST
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
The 7 Hottest Healthcare Stocks to Own for 2023 and Beyond
These seven hottest healthcare stocks have strong growth catalysts that could send each of them higher over the next few years.
Why Viatris Stock Is Jumping Today
Investors are applauding a key step in Viatris' plans to return to growth.
Mentions: VTRS
Viatris Bolsters Its Ophthalmology Franchise With Oyster Point Pharma Deal, Shares Surge
Mentions: VTRS
Viatris (VTRS) Stock Pops 17% on Acquisition News
One press release with numerous positive catalysts is prompting some VTRS stock traders to load up on the shares today.
Mentions: VTRS
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates APEN, SAL, LBC, OYST
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AGFS, ATCO, LBC, OYST
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
Oyster Point Pharma, Inc., Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PRINCETON, N.J., Dec. 02, 2022 (GLOBE NEWSWIRE) -- Oyster Point Pharma, Inc., (Nasdaq: OYST), (“Oyster Point Pharma”, or “the Company”), a...
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates OYST, LBC, ELVT, IMGO
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
Better Dividend Stock: AbbVie or Viatris?
These pharmaceutical companies are profitable and offer above-average dividends.
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BTRS, USER, AGFS, OYST
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
SHAREHOLDER ALERT: Weiss Law Reminds AGTC, OYST, VLDR, and BTRS Shareholders About Its Ongoing Investigations
/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ABMD, BNFT, OYST, VLDR
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
Oyster Point Pharma GAAP EPS of -$1.37 misses by $0.11, revenue of $5.59M misses by $8.72M (NASDAQ:OYST)
Oyster Point Pharma press release (OYST): Q3 GAAP EPS of -$1.37 misses by $0.11.Revenue of $5.59M (-68.8% Y/Y) misses by $8.72M.
SHAREHOLDER ALERT: Weiss Law Reminds OYST, VLDR, ECOM, and LOTZ Shareholders About Its Ongoing Investigations
/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...
Oyster Point Pharma Reports Third Quarter 2022 Financial Results and Recent Business Highlights
TYRVAYA® (Varenicline Solution) Nasal Spray Achieved Net Product Revenue of $5.6 Million in Q3’22Approximately 34,000 TYRVAYA Prescriptions Filled During...
SHAREHOLDER ALERT: Weiss Law Investigates Oyster Point Pharma, Inc.
/PRNewswire/ -- Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Oyster Point Pharma,...
Mentions: VTRS
SHAREHOLDER ALERT: Halper Sadeh LLC Investigates OYST, OUST, and RBA
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
Shareholder Alert: Ademi LLP investigates whether Oyster Point Pharma, Inc. has obtained a Fair Price in its transaction with Viatris
/PRNewswire/ -- Ademi LLP is investigating Oyster Point Pharma (NASDAQ: OYST) for possible breaches of fiduciary duty and other violations of law in its...
OYST Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Oyster Point Pharma, Inc. Is Fair to Shareholders
Oyster Point Pharma, a Leading Ophthalmology-Focused Biopharmaceutical Company, to be Acquired by Viatris
Tender Offer to Acquire All Outstanding Shares of Oyster Point Pharma for $11.00 per Share, Plus a Contingent Value Right of Up To $2.00 per Share ...